Protocadherin 17 promoter methylation in tumour tissue from patients with bladder transitional cell carcinoma (Q28307954)

0 references

Zhi-Gang Li

0 references

Jian-Hua Ma

0 references

Jian Li

0 references

Jian-Guo Ma

Journal of International Medical Research

0 references

language of work or name

English

0 references

publication date

April 2014

0 references

published in

0 references

volume

0 references

issue

0 references

page(s)

292-9

0 references

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1177%2F0300060513504364

The present and future burden of urinary bladder cancer in the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513504364

Can the burden of follow-up in low-grade noninvasive bladder cancer be reduced by photodynamic diagnosis, perioperative instillations, imaging, and urine markers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513504364

Hypermethylation of TWIST1 and NID2 in tumor tissues and voided urine in urinary bladder cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513504364

Epigenetic alterations in bladder cancer and their potential clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513504364

Epigenetics of kidney cancer and bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513504364

Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513504364

Cadherins in collective cell migration of mesenchymal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513504364

Clinical and prognostic significance of protocadherin-10 (PCDH10) promoter methylation in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513504364

Non-clustered protocadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513504364

TCF21 and PCDH17 methylation: An innovative panel of biomarkers for a simultaneous detection of urological cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513504364

Guidelines on bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513504364

Clinical significance of protocadherin-8 (PCDH8) promoter methylation in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513504364

Cathepsin L is associated with proliferation and clinical outcome of urothelial carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513504364

Methylation of a novel panel of tumor suppressor genes in urine moves forward noninvasive diagnosis and prognosis of bladder cancer: a 2-center prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513504364

DNA methylation and cancer diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513504364

DNA methylation-based biomarkers in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513504364

Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513504364

Defining optimal therapy for muscle invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513504364

Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513504364

Clinical Significance of CDH13 Promoter Methylation in Serum Samples from Patients with Bladder Transitional Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513504364